RIVICICLIB

/static/temp/default.svg

Search structure


Synonyms	P 276-00 free base P-276-00 free base P276-00 Riviciclib
Status
Molecule Category	UNKNOWN
UNII	9EK26WE8QN


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	QLUYMIVVAYRECT-UHFFFAOYSA-N
Smiles	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C1CO
InChI	InChI=1S/C21H20ClNO5/c1-23-7-6-12(14(23)10-24)19-15(25)8-16(26)20-17(27)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,14,24-26H,6-7,10H2,1H3

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C21H20ClNO5
Molecular Weight	401.85
AlogP	3.3
Hydrogen Bond Acceptor	6.0
Hydrogen Bond Donor	3.0
Number of Rotational Bond	3.0
Polar Surface Area	94.14
Molecular species	NEUTRAL
Aromatic Rings	3.0
Heavy Atoms	28.0

Bioactivity

Mechanism of Action	Action	Reference
Cyclin-dependent kinase 1 inhibitor	INHIBITOR	PubMed PubMed


Protein: Cyclin-dependent kinase 1 Description: Cyclin-dependent kinase 1 Organism : Homo sapiens P06493 ENSG00000170312













Protein: Cyclin-dependent kinase 4 Description: Cyclin-dependent kinase 4 Organism : Homo sapiens P11802 ENSG00000135446











Protein: Cyclin-dependent kinase 9 Description: Cyclin-dependent kinase 9 Organism : Homo sapiens P50750 ENSG00000136807

Related Entries

Cross References

Resources	Reference
ChEMBL	CHEMBL3545283
FDA SRS	9EK26WE8QN
PubChem	24887371
SureChEMBL	SCHEMBL665748

CONTENTS

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).